Bio

Asher Funk is a partner in the Private Equity group at Goodwin. Asher represents healthcare and life sciences clients during transactional, strategic, and regulatory compliance matters. He serves as a trusted advisor to private equity investors and their portfolio companies, as well as emerging and late-stage healthcare companies on operational issues, mergers, acquisitions, dispositions, and joint ventures. Asher’s experience in the healthcare vertical spans the continuum of care, and includes hospitals, health systems, physician practices, skilled nursing facilities, rehabilitation providers, home health and hospice companies, specialty pharmacies, durable medical equipment suppliers, digital health entities, and behavioral health providers. Asher has vast knowledge of the Stark Law, Anti-Kickback Statute, Civil Monetary Penalties Law, and issues related to quality of care, medical necessity, billing, and reimbursement. He represents clients during self-disclosures to Medicare contractors, the HHS/OIG, CMS, and the Department of Justice (DOJ). Additionally, Asher has negotiated corporate integrity agreements with the HHS/OIG and advised companies operating under integrity agreements. Asher also has a deep understanding of matters involving the federal False Claims Act (FCA) and similar state laws. He has defended healthcare providers facing investigations and government enforcement actions, helped clients avoid intervention by the DOJ, and when necessary, guided clients to reach settlements with the government. Asher frequently draws on his FCA and fraud & abuse experience to address the complex issues and challenges that arise in healthcare transactions, and to assist investors when vetting potential acquisition targets and their business models.